LCT Share Price

Open 0.09 Change Price %
High 0.09 1 Day 0.00 0.00
Low 0.09 1 Week 0.01 12.50
Close 0.09 1 Month 0.00 0.00
Volume 1381120 1 Year 0.05 125.00
52 Week High 0.11
52 Week Low 0.04
LCT Important Levels
Resistance 2 0.09
Resistance 1 0.09
Pivot 0.09
Support 1 0.09
Support 2 0.09
ASX Australia Most Active Stocks
AYR 0.01 0.00%
AYR 0.01 0.00%
AYR 0.01 0.00%
AGO 0.05 25.00%
AGO 0.05 25.00%
AGO 0.05 25.00%
DDD 0.01 0.00%
DDD 0.01 0.00%
DDD 0.01 0.00%
BUR 0.02 0.00%
More..
ASX Australia Top Gainers Stocks
KSO 0.40 3900.00%
RHT 0.03 50.00%
RHT 0.03 50.00%
EXG 0.03 50.00%
EXG 0.03 50.00%
CDY 0.03 50.00%
CDY 0.03 50.00%
PMQ 0.03 50.00%
IRM 0.03 50.00%
IRM 0.03 50.00%
More..
ASX Australia Top Losers Stocks
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
TCQ 0.27 -73.53%
GDY 0.01 -50.00%
GPP 0.02 -33.33%
BMN 0.04 -20.00%
ICP 0.04 -20.00%
ICP 0.04 -20.00%
More..

Living Cell Technologies Ltd (ASX: LCT)

LCT Technical Analysis 3
As on 18th Jan 2017 LCT Share Price closed @ 0.09 and we RECOMMEND Buy for LONG-TERM with Stoploss of 0.07 & Buy for SHORT-TERM with Stoploss of 0.09 we also expect STOCK to react on Following IMPORTANT LEVELS.
LCT Target for January
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
LCT Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.lctglobal.com
LCT Address
LCT
Hunters Corner
PO Box 23566
Auckland, 2155
New Zealand
Phone: 64 9 276 2690
Fax: 64 9 276 2691
LCT Latest News
Checking Moving Average and RSI Levels on Living Cell Technologies Limited ...   StockTalk Daily   - 11th Jan 17
Group 2 Parkinson's Trial Patients' Treatment Completed   irasia.com (press release)   - 22nd Dec 16
BRIEF-Living Cell Technologies Seeks trading halt   Reuters   - 24th Nov 16
Living Cell Technologies Ltd in an ASX trading halt   Proactive Investors Australia   - 24th Nov 16
Living Cell Technologies to tap investors via placement   The Australian Financial Review   - 24th Nov 16
Living Cell Technologies Ltd advancing clinical trial for Parkinson's   Proactive Investors Australia   - 05th Oct 16
NTCELL® Continues to Reverse the Progression of Parkinson's Disease - One Year ...   irasia.com (press release)   - 27th Jan 16
Update to DIABECELL Development Strategy   irasia.com (press release)   - 26th Jun 15
Welcome to the Scoop InfoPages   Scoop.co.nz   - 18th Jul 13
Andrew Patterson talks Andrea Grant at Living Cell Technologies, a company ...   Interest.co.nz   - 14th May 13
Interactive Technical Analysis Chart Living Cell Technologies Ltd ( LCT ASX Australia )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Living Cell Technologies Ltd
LCT Business Profile
Living Cell Technologies Limited, a cell implant company, develops living cell products for the treatment of diabetes and neurological diseases primarily in New Zealand. The company’s technology, IMMUPEL, coats cells with protective capsules that prevent them from attack by the patient’s immune system. Its product pipeline includes DIABECELL, a porcine insulin-producing cell product for the treatment of type 1 diabetes; and NTCELL, a choroid plexus cell product to treat Parkinson's disease and other disorders, such as stroke, Huntington's disease, and hearing loss, as well as wound hearing. Living Cell Technologies Limited was founded in 1987 and is based in Auckland, New Zealand.